<prompt> All of the statements about exenatide are true except:It is a GLP1 analogueIt can be used for treatment of Type 1 diabetes mellitusIt is given subcutaneouslyIt decreases glucagon  <response>: Exenatide Exendin 4 is a GLP-1 receptor agonist that is more resistant to DPP-4 action and cleared by the kidney.When this drug is given to patients with type 2 diabetes by subcutaneous injection twice daily, it lowers blood glucose and HbA1c levels. It is not indicated in type 1 diabetes.Exenatide appears to have the same effects as GLP-1 on glucagon suppression and gastric emptying.Only drugs approved for treatment of type 1 diabetes are insulin and pramlintide. 